DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Sold by Silvercrest Asset Management Group LLC

Silvercrest Asset Management Group LLC cut its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 97.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 41,189 shares of the medical instruments supplier’s stock after selling 1,557,136 shares during the quarter. Silvercrest Asset Management Group LLC’s holdings in DENTSPLY SIRONA were worth $782,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also made changes to their positions in the stock. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $143,000. Point72 Asset Management L.P. acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $179,000. Quantinno Capital Management LP grew its stake in shares of DENTSPLY SIRONA by 58.7% during the 4th quarter. Quantinno Capital Management LP now owns 185,399 shares of the medical instruments supplier’s stock worth $3,519,000 after purchasing an additional 68,591 shares during the period. Man Group plc grew its stake in shares of DENTSPLY SIRONA by 375.1% during the 4th quarter. Man Group plc now owns 177,962 shares of the medical instruments supplier’s stock worth $3,378,000 after purchasing an additional 140,503 shares during the period. Finally, Nomura Holdings Inc. acquired a new position in shares of DENTSPLY SIRONA during the 4th quarter worth $501,000. 95.70% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

XRAY has been the topic of several recent research reports. StockNews.com upgraded shares of DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a research report on Friday, May 9th. Mizuho decreased their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating on the stock in a research report on Thursday, March 13th. Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their price objective for the stock from $30.00 to $20.00 in a research report on Thursday, January 23rd. UBS Group decreased their price objective on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating on the stock in a research report on Friday, May 9th. Finally, Piper Sandler decreased their price objective on shares of DENTSPLY SIRONA from $20.00 to $16.00 and set a “neutral” rating on the stock in a research report on Wednesday, April 30th. Eleven equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $20.36.

Insider Buying and Selling at DENTSPLY SIRONA

In related news, Director Gregory T. Lucier acquired 15,142 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the acquisition, the director now directly owns 81,971 shares in the company, valued at approximately $1,353,341.21. The trade was a 22.66% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at the SEC website. 0.50% of the stock is owned by insiders.

DENTSPLY SIRONA Price Performance

NASDAQ:XRAY opened at $16.71 on Wednesday. The firm has a market cap of $3.33 billion, a price-to-earnings ratio of -8.07, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company’s 50-day moving average is $14.47 and its two-hundred day moving average is $17.25. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $28.44.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.14. The company had revenue of $879.00 million for the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The firm’s quarterly revenue was down 7.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.42 EPS. Research analysts expect that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were issued a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a yield of 3.83%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is -14.10%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.